Medical R&D timelines are being reduced by 30-80% through AI application to drug targeting and novel drug use case discovery, where AI searches through past academic papers and chemical structures to identify novel targets for existing drugs, providing a simpler profitability path than developing entirely new drugs.
factualpending
Evidence Quote
“30 to 80% reduction in medical R&D timelines which is wild. This one doesn't get publicized enough.”
Created: 8/11/2026, 7:38:24 AM
Your notes
Loading notes...